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Introduction
Since it was first proposed that the innate immune system could
recognise conserved microbial-associated molecular patterns (or
PAMPs) through inherited receptors expressed by the host (termed
pattern recognition receptors, or PRRs), several families of PRRs
have been discovered and characterised. The most famous of these
are the Toll-like receptors (TLRs), but there is growing appreci-
ation that another large family of PRRs, known as the C-type
lectin receptors (CLRs), also play a major role in antimicrobial
immunity. CLRs have one or more carbohydrate recognition
domains (CRDs) that recognise a wide variety of carbohydrate
ligands. Other members of the CLR family, which do not
recognise carbohydrate ligands but contain similar protein folds
called C-type lectin-like domains (CTLD), have also been
discovered and are included in this large family whose members
are divided into 17 groups relating to phylogeny and structure.
Upon ligand binding, some CLRs (such as Dectin-1, Dectin-2, and
Mincle) undergo intracellular signalling to drive cellular responses.
Here, we outline the signalling pathways downstream of these
receptors and discuss how they, and some other CLRs (including
the Mannose Receptor, CLEC5A, CLEC9A, and DC-SIGN),
contribute to immunity against fungi, bacteria, viruses, and
parasites.
CLRs Can Initiate Complex Intracellular Signalling
Pathways
Signalling by CLRs has multiple cellular consequences,
including phagocytosis, activation of innate killing mechanisms
(e.g., the respiratory burst), and inflammatory mediator produc-
tion. Although incompletely understood, CLRs can trigger
intracellular signalling through integral signalling motifs (such as
immunoreceptor tyrosine-based activation motifs, or ITAMs) or
by association with signalling adaptor molecules (such as the
ITAM-containing FcRc) [1,2].
One of the best characterised signalling pathways downstream
of CLRs is the Syk kinase/CARD9 pathway that is utilised by
several CLRs including Dectin-1 (gene symbol Clec7a), Dectin-2
(Clec4n), and Mincle (Clec4e) [1,2]. Syk is recruited following
phosphorylation of tyrosines in the ITAM motif of these receptors,
and the subsequent activation leads to the formation of a
trimolecular complex composed of CARD9, Bcl10, and MALT1.
This complex in turn is involved in the activation of NFkB, a
major inflammatory transcription factor driving production of IL-
6, pro-IL-1b, and TNFa (among others) [2].
Of particular recent interest is the ability of CLRs, such as
Dectin-1, to activate inflammasomes—intracellular proteolytic
complexes that utilise caspase-1 to generate active IL-1b.
However, the process of inflammasome activation can be complex,
as Dectin-1-dependent activation of the NLRP3 inflammasome
was shown to require phagocytosis, suggesting that additional
intracellular mechanism(s) were involved in these responses. On
the other hand, Dectin-1 was also recently shown to activate a
novel inflammasome involving caspase-8—a response that did not
require internalisation, suggesting a direct extracellular sensing
mechanism [3].
The importance of these pathways has been highlighted by the
phenotypes observed in murine gene knockout models and with
human mutations. For example, a deficiency in CARD9
significantly enhances susceptibility to fungal infections in both
mice and humans, and is more severe than a deficiency in any
single receptor, indicating that redundancy between CLRs is
common [2,4] and also highlighting the possible involvement of
other non-CLR receptors that utilise CARD9. Indeed, pathogens
possess multiple PAMPs and will engage several PRRs during an
immune response, and this allows for ‘‘fine-tuning’’ of signalling
that shapes the cellular response appropriately. CLR cross-talk can
be critical to protection, and several examples of this have recently
been described [5]. The medical relevance of CLR signalling
means that further understanding of these processes is essential if
we are to gain insights into how stimulating different CLRs gives
varying responses despite the utilisation of common signalling
pathways.
Fungi
CLRs have been best studied in the context of fungal
infections—an area of research which has gained increasing
attention due to the substantial increase in the number of life-
threatening fungal infections in recent years. Several CLRs have
been implicated in antifungal immunity and include Dectin-1,
Dectin-2, the Mannose Receptor (MR), and Mincle (Table 1).
Dectin-1 is the most extensively characterised antifungal receptor
and has been shown to play vital roles in the defence against an
array of fungal pathogens, including C. albicans, A. fumigatus, and P.
carinii [6]. Dectin-1 recognises fungi by binding b-glucans in the
fungal cell wall, and subsequently signals through Syk/CARD9 to
induce cellular responses including phagocytosis, induction of the
respiratory burst, and cytokine production. Another recently
described function is the ability of Dectin-1 to directly induce
adaptive Th1 and Th17 responses [2]. Dectin-12/2 mice have
been used to demonstrate how these functions are important for
antifungal immunity in vivo. Inefficient fungal uptake and killing in
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Dectin-12/2 mice leads to uncontrolled fungal growth in mouse
models of systemic candidiasis and aspergillosis, leading to an
enhanced rate of mortality [6]. Furthermore, Dectin-12/2 mice
and humans with a mutation in the Dectin-1 gene (leading to a
non-expressed truncated form of Dectin-1) can present with an
increased susceptibility to mucosal candidiasis and aspergillosis
[2,6], in part due to aberrant induction of adaptive immunity.
Like Dectin-1, Dectin-2 also plays a key role in the protection
against C. albicans, through innate recognition and the promotion
of Th17 responses [7,8]. The roles of the MR and Mincle are less
well defined however. MR contains no known signalling motifs
and it is unclear whether signalling occurs directly from the MR,
and MR2/2 mice do not have increased susceptibility to most
fungal pathogens, with the exception of C. neoformans [9]. Mincle,
on the other hand, has contradicting studies on the species it
recognises [10] possibly because of fungal strain variation, which
can be important to the interpretation of these types of studies [6].
Defining the roles of these receptors will hopefully help feed
development of novel therapeutics and vaccines, of which there
are currently few effective options for the former, and none for the
latter.
Bacteria
The majority of studies analysing the role of CLRs in bacterial
infections have focused on mycobacterial diseases, and we will
focus on this data here. However it is important to note that,
although less well characterised, CLRs have been implicated in the
recognition of other bacterial species. For example, the MR
recognises a number of bacteria including Klebsiella and Streptococcus
species [11].
Several CLRs recognise mycobacteria and play roles in the
resulting immune responses. The MR has been shown to mediate
the binding and internalisation of mycobacteria, and plays a role
in antigen presentation and the promotion of T-cell responses
[11]. Mincle and Dectin-1 have also been linked to mycobacterial
recognition, although Mincle’s ligand is the only one to be
identified (mycobacterial cord factor, also known as TDM).
Despite their ability to recognise mycobacteria, none of the
receptor-deficient mouse models exhibit increased susceptibility to
infection [10,12]. This suggests that other receptors are able to
compensate, and that there is a high level of redundancy for
mycobacterial recognition. However, while individual receptors
appear redundant, the shared downstream signalling pathway
appears to be central for protection as CARD92/2 mice are
highly susceptible to mycobacterial infection [10].
Viruses
Unlike fungi and bacteria in which these receptors are thought
to play protective roles, many CLRs involved in viral recognition
appear to promote transmission and infection. One of the best
characterised examples is DC-SIGN and HIV. Viral particles bind
DC-SIGN via gp120 on the viral surface before being endocytosed
by dendritic cells (DCs), and HIV is then thought to use the DC as
a safe mode of transport to lymph nodes where it comes into
contact with its target CD4+ T-cells. Indeed, various human DC-
SIGN polymorphisms have been associated with increased
transmission and binding of HIV [13]. Other examples include
binding of dengue virus (DV) by CLEC5A and the MR, and
blocking these CLRs in experimental models prevented viral
growth and associated lethal inflammation [14–16].
On the other hand, CLRs can also play protective roles during
viral infections, some through indirect mechanisms. For example,
CLEC9A (also known as DNGR-1) was recently shown to
facilitate antigen cross-presentation, a function required for the
control of infections with vaccinia virus [17] and herpes simplex
virus [18].
Parasites
Many parasites express a large number of carbohydrates, and
therefore have the potential to engage host CLRs. Dectin-2, while
typically considered an antifungal CLR, can also contribute to
immunity against parasitic worms. Dectin-2 was recently shown to
recognise a component of Schistosoma mansoni egg antigen (SEA),
Table 1. Selected CLRs, their microbial ligands, and the microbes that have altered ability to infect in the absence of the receptor
within mice and humans.
CLR Identified Microbial Ligand(s)
Infections with Altered
Susceptibility in the Mouse KO
Infections Linked to Human
Polymorphisms Selected References






Dectin-2 a-mannan q C. albicans None identified/confirmed [7]
DC-SIGN* ManLAM (mycobacteria)
gp120 (HIV)





Mannan/mannose q Cryptococcus neoformans q M. tuberculosis [9,11,24]
CLEC5A Dengue virus** Q Dengue virus*** None identified/confirmed [15,16]






A selection of CLRs are listed with identified microbial ligands and phenotypes observed with different pathogens in both mice and humans, where q denotes
enhanced susceptibility of the host and Q denotes enhanced resistance.
*DC-SIGN is a human molecule with related homologues in the mouse; mouse phenotypes described are for SIGNR3 knockouts.
**Exact ligand on DV is unknown.
***These experiments were performed using blocking antibodies to CLEC5A. Abbreviations: HIV, human immunodeficiency virus; ManLAM, mannosylated
lipoarabinomannan; TDM, trehalose-6, 69-dimycolate.
doi:10.1371/journal.ppat.1003417.t001
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and was responsible for the subsequent activation of the NLRP3
inflammasome. While absence of this inflammatory response did
not alter parasite burden, it did alleviate Th2-mediated immuno-
pathology [19]. Interestingly, Dectin-2 has also been shown to
promote Th2 responses to the common allergen house dust mite
(HDM) antigen [2], while Th17 responses are seen with fungi (see
above). However, it is not well understood how Dectin-2 can
promote opposing T-cell responses to different antigens, although
further definition of the downstream signalling pathways following
recognition should help answer these questions.
Like Dectin-2, other CLRs have also been found to modulate
adaptive immune responses to parasites. For example, the MR was
shown to help drive the protective Th2 response during S. mansoni
infection and enhance uptake of infectious cercariae [20].
CLEC9A, on the other hand, was shown to drive CD8+ T-cell
activation (possibly through previously described cross-presenta-
tion functions) during cerebral malaria in mice, resulting in
immunopathology and mortality [21].
Concluding Remarks
CLRs are involved in immunity to several classes of microbe,
from initial recognition and uptake to modulation of adaptive
immunity. Indeed, although not discussed here, CLRs have also
been implicated in maintaining immune homeostasis through
recognition of endogenous ligands; both Mincle and CLEC9A are
involved in the recognition of necrotic cells by binding exposed
nuclear proteins and actin filaments, respectively [22,23]. How-
ever, much is still to be learned about these innate receptors, such
as the specific outcomes of cross-talk during signalling and how
this is regulated. Furthermore, microbial ligands for many CLRs
remain unidentified. Unveiling the microbial components that
stimulate potent immune responses via CLRs is an important
avenue for research into novel vaccines and therapies. Moreover,
as our knowledge grows it is likely that we will identify additional
human CLR polymorphisms that cause defects in antimicrobial
immunity.
References
1. Drummond RA, Saijo S, Iwakura Y, Brown GD (2011) The role of Syk/
CARD9 coupled C-type lectins in antifungal immunity. Eur J Immunol 41: 276–
281.
2. Hardison SE, Brown GD (2012) C-type lectin receptors orchestrate antifungal
immunity. Nat Immunol 13: 817–822.
3. Gringhuis SI, Kaptein TM, Wevers BA, Theelen B, van der Vlist M, et al. (2012)
Dectin-1 is an extracellular pathogen sensor for the induction and processing of
IL-1b via a noncanonical caspase-8 inflammasome. Nat Immunol 13: 246–254.
4. Glocker EO, Hennigs A, Nabavi M, Schaffer AA, Woellner C, et al. (2009) A
homozygous CARD9 mutation in a family with susceptibility to fungal
infections. N Engl J Med 361: 1727–1735.
5. da Glo´ria Sousa M, Reid Delyth M, Schweighoffer E, Tybulewicz V, Ruland J,
et al. (2011) Restoration of pattern recognition receptor costimulation to treat
chromoblastomycosis, a chronic fungal infection of the skin. Cell Host Microbe
9: 436–443.
6. Drummond RA, Brown GD (2011) The role of Dectin-1 in the host defence
against fungal infections. Curr Opin Microbiol 14: 392–399.
7. Saijo S, Ikeda S, Yamabe K, Kakuta S, Ishigame H, et al. (2010) Dectin-2
recognition of a-mannans and induction of Th17 cell differentiation is essential
for host defense against Candida albicans. Immunity 32: 681–691.
8. Gringhuis SI, Wevers BA, Kaptein TM, van Capel TMM, Theelen B, et al.
(2011) Selective c-Rel activation via Malt1 controls anti-fungal TH-17 immunity
by Dectin-1 and Dectin-2. PLoS Pathog 7: e1001259. doi:10.1371/journal.-
ppat.1001259.
9. Dan JM, Kelly RM, Lee CK, Levitz SM (2008) Role of the mannose receptor in
a murine model of Cryptococcus neoformans infection. Infect Immun 76: 2362–2367.
10. Marakalala MJ, Graham LM, Brown GD (2010) The role of Syk/CARD9-
coupled C-type lectin receptors in immunity to Mycobacterium tuberculosis
infections. Clin Dev Immunol 2010: 567571.
11. Gazi U, Martinez-Pomares L (2009) Influence of the mannose receptor in host
immune responses. Immunobiology 214: 554–561.
12. Tanne A, Ma B, Boudou F, Tailleux L, Botella H, et al. (2009) A murine DC-
SIGN homologue contributes to early host defense against Mycobacterium
tuberculosis. J Exp Med 206: 2205–2220.
13. Boily-Larouche G, Milev MP, Zijenah LS, Labbe´ A-C, Zannou DM, et al.
(2012) Naturally-occurring genetic variants in human DC-SIGN increase HIV-1
capture, cell-transfer and risk of mother-to-child transmission. PLoS ONE 7:
e40706. doi:10.1371/journal.pone.0040706.
14. Miller JL, de Wet BJM, Martinez-Pomares L, Radcliffe CM, Dwek RA, et al.
(2008) The mannose receptor mediates dengue virus infection of macrophages.
PLoS Pathog 4: e17. doi:10.1371/journal.ppat.0040017.
15. Wu MF, Chen ST, Yang AH, Lin WW, Lin YL, et al. (2013) CLEC5A is critical
for dengue virus-induced inflammasome activation in human macrophages.
Blood 121: 95–106.
16. Chen S-T, Lin Y-L, Huang M-T, Wu M-F, Cheng S-C, et al. (2008) CLEC5A is
critical for dengue-virus-induced lethal disease. Nature 453: 672–676.
17. Iborra S, Izquierdo HM, Martı´nez-Lo´pez M, Blanco-Mene´ndez N, Reis e Sousa
C, et al. (2012) The DC receptor DNGR-1 mediates cross-priming of CTLs
during vaccinia virus infection in mice. J Clin Invest 122: 1628–1643.
18. Zelenay S, Keller AM, Whitney PG, Schraml BU, Deddouche S, et al. (2012)
The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell
antigens to favor cross-priming of CTLs in virus-infected mice. J Clin Invest 122:
1615–1627.
19. Ritter M, Gross O, Kays S, Ruland J, Nimmerjahn F, et al. (2010) Schistosoma
mansoni triggers Dectin-2, which activates the Nlrp3 inflammasome and alters
adaptive immune responses. Proc Natl Acad Sci U S A 107: 20459–20464.
20. Paveley RA, Aynsley SA, Turner JD, Bourke CD, Jenkins SJ, et al. (2011) The
Mannose Receptor (CD206) is an important pattern recognition receptor (PRR)
in the detection of the infective stage of the helminth Schistosoma mansoni and
modulates IFN gamma production. Int J Parasit 41: 1335–1345.
21. Piva L, Tetlak P, Claser C, Karjalainen K, Renia L, et al. (2012) Cutting edge:
Clec9A(+) dendritic cells mediate the development of experimental cerebral
malaria. J Immunol 189: 1128–1132.
22. Brown GD (2008) Sensing necrosis with Mincle. Nat Immunol 9: 1099–1100.
23. Sancho D, Joffre OP, Keller AM, Rogers NC, Martinez D, et al. (2009)
Identification of a dendritic cell receptor that couples sensing of necrosis to
immunity. Nature 458: 899–903.
24. Azad AK, Sadee W, Schlesinger LS (2012) Innate immune gene polymorphisms
in tuberculosis. Infect Immun 80: 3343–3359.
PLOS Pathogens | www.plospathogens.org 3 July 2013 | Volume 9 | Issue 7 | e1003417
